Eli Lilly and Company (LLY) said Monday it has broken ground on a $6.5 billion manufacturing facility in Houston, Texas, that will produce its oral GLP-1 drug Foundayo along with other small-molecule medicines and advanced therapeutics.
Lilly said the facility is expected to create more than 600 high-wage jobs and roughly 4,000 construction jobs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments